SCHEMBL17181733

SCHEMBL17181733

CCOC(=O)CC(=O)N(OCc1ccc(C(F)(F)F)cc1)c1ncccc1C(=O)OCC

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.45
HTT P42858 2/20 0.45
ALDH1A1 P00352 2/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
L3MBTL1 Q9Y468 5/20 0.44
MAPK1 P28482 2/20 0.44
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
LMNA P02545 1/20 0.41
MAOB P27338 1/20 0.41
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
PPIA P62937 1/20 0.39
GAA P10253 2/20 0.39
POLB P06746 1/20 0.39
MRGPRX4 Q96LA9 1/20 0.39
TDP1 Q9NUW8 1/20 0.38
HPGD P15428 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1522806 0.88 L3MBTL1 (0.55) MAPTHTTALDH1A1SMN1; SMN2L3MBTL1
SCHEMBL16236403 0.83 L3MBTL1 (0.54) MAPTHTTALDH1A1SMN1; SMN2L3MBTL1
SCHEMBL3516526 0.80 L3MBTL1 (0.55) MAPTHTTALDH1A1SMN1; SMN2L3MBTL1
SCHEMBL3519261 0.79 L3MBTL1 (0.54) MAPTHTTALDH1A1SMN1; SMN2L3MBTL1
SCHEMBL1522651 0.79 HSD17B10 (0.46) MAPTHTTALDH1A1SMN1; SMN2L3MBTL1
SCHEMBL17181734 0.78 HTT (0.53) MAPTHTTALDH1A1SMN1; SMN2L3MBTL1
SCHEMBL3515081 0.72 L3MBTL1 (0.42) MAPTALDH1A1SMN1; SMN2L3MBTL1MAPK1
SCHEMBL15846420 0.71 TSHR (0.48) ALDH1A1SMN1; SMN2L3MBTL1MAPK1KMT2A
SCHEMBL2858512 0.71 TRPV1 (0.51) MAPTHTTALDH1A1SMN1; SMN2L3MBTL1
SCHEMBL23423499 0.71 HTT (0.57) MAPTHTTALDH1A1SMN1; SMN2MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2935221-B1 QUINOLONE DERIVATIVES CADILA HEALTHCARE LTD (IN) 2018-02-07 EP disclosed
US-9394300-B2 Quinolone derivatives CADILA HEALTHCARE LIMITED (IN) 2016-07-19 US disclosed
US-20150299193-A1 NOVEL QUINOLONE DERIVATIVES CADILA HEALTHCARE LIMITED (IN) 2015-10-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150299193-A1 NOVEL QUINOLONE DERIVATIVES NQO2, UGT1A1, CYP11B2 MAPT 216/4885HTT 1850/4885ALDH1A1 2214/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.